Cpr951 发表于 2025-3-25 05:13:26

Submitted on: 11 September 2017.
Revised on: 17 November 2017.
Accepted on: 29 November 2017.

___________________EJNMMI Radiopharmacy and Chemistry

巩固 发表于 2025-3-25 08:25:25

Submitted on: 11 March 2005.
Revised on: 06 April 2005.
Accepted on: 02 June 2005.

___________________EJNMMI Radiopharmacy and Chemistry

Nonporous 发表于 2025-3-25 13:47:27

http://reply.papertrans.cn/1/82/8154/8154-23.png

可转变 发表于 2025-3-25 16:10:11

Submitted on: 03 October 2008.
Revised on: 26 October 2008.
Accepted on: 16 December 2008.

___________________EJNMMI Radiopharmacy and Chemistry

enmesh 发表于 2025-3-25 22:11:13

http://reply.papertrans.cn/1/82/8154/8154-25.png

Amorous 发表于 2025-3-26 02:22:19

Submitted on: 24 July 2009.
Revised on: 17 August 2009.
Accepted on: 13 September 2009.

___________________EJNMMI Radiopharmacy and Chemistry

Expressly 发表于 2025-3-26 06:43:54

http://reply.papertrans.cn/1/82/8154/8154-27.png

名义上 发表于 2025-3-26 12:00:13

Submitted on: 02 August 2004.
Revised on: 20 November 2004.
Accepted on: 20 December 2004.

___________________EJNMMI Radiopharmacy and Chemistry

膝盖 发表于 2025-3-26 13:04:16

Submitted on: 01 April 2006.
Revised on: 18 June 2006.
Accepted on: 30 June 2006.

___________________EJNMMI Radiopharmacy and Chemistry

GEON 发表于 2025-3-26 17:51:23

http://reply.papertrans.cn/1/82/8154/8154-30.png
页: 1 2 [3] 4
查看完整版本: ESCI期刊EJNMMI Radiopharmacy and Chemistry 2024/2025影响因子:4.472 (EJNMMI RADIOPHARM CH) (NULL). (CHEMISTRY, INORGANIC & NUC